Adding Dosing Of Plasmid Encoding P62/Sqstm1 To Gemcitabine Chemotherapy May Provide Clinical Benefits To Patients With Platinum-Resistant Ovarian Cancer S. Polyakov, S. Krasny,E. Zhavrid,Y. Baranau, O. Sergeeva, K. Zharkova, A. Khorau, S. Kozlovskaya,V. Gabai,A. ShneiderANNALS OF ONCOLOGY（2021）引用 3|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
